Gerard M. Jensen
Impact in
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
- Pharmaceutical Science top 5%
Papers in
-
- Antifungal resistance and susceptibility 6
- Co-authors
- David B. Goodin (5 shared papers)Jill Adler‐Moore (3 shared papers)Jon Olson (3 shared papers)Steven W. Bunte (2 shared papers)Duncan E. McRee (3 shared papers)Rabi A. Musah (2 shared papers)R.J. Rosenfeld (2 shared papers)Julie Schwartz (2 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (3 papers)Journal of Liposome Research (2 papers)Journal of the American Chemical Society (2 papers)Journal of Molecular Biology (1 paper)Advanced Drug Delivery Reviews (1 paper)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Gerard M. Jensen
17 papers receiving 745 citations
Peers
Comparison fields: 5 of 91
- Infectious Diseases 197
- Pharmaceutical Science 61
- Physical and Theoretical Chemistry 53
- Microbiology 34
- Biomaterials 71
Countries citing papers authored by Gerard M. Jensen
This map shows the geographic impact of Gerard M. Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard M. Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard M. Jensen more than expected).
Fields of papers citing papers by Gerard M. Jensen
This network shows the impact of papers produced by Gerard M. Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard M. Jensen. The network helps show where Gerard M. Jensen may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerard M. Jensen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 139 | |
| 2 | 1997 | 102 | |
| 3 | 2020 | 65 | |
| 4 | 2007 | 60 | |
| 5 | 2006 | 59 | |
| 6 | 2010 | 51 | |
| 7 | 2002 | 47 | |
| 8 | 1996 | 41 | |
| 9 | 1998 | 35 | |
| 10 | 1992 | 30 | |
| 11 | 1995 | 28 | |
| 12 | 2007 | 26 | |
| 13 | 2001 | 25 | |
| 14 | 2017 | 24 | |
| 15 | 1996 | 15 | |
| 16 | 2010 | 9 | |
| 17 | New liposomal formulations of cisplatin with improved therapeutic index | 2004 | 3 |
About Gerard M. Jensen
Gerard M. Jensen is a scholar working on Infectious Diseases, Molecular Biology, Epidemiology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 759 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (6 papers), Fungal Infections and Studies (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Allergic Rhinitis and Sensitization (1 paper), Supramolecular Chemistry and Complexes (1 paper) and Inhalation and Respiratory Drug Delivery (1 paper). The work is most often cited by research in Infectious Diseases (197 citations), Pharmaceutical Science (61 citations), Physical and Theoretical Chemistry (53 citations), Microbiology (34 citations) and Biomaterials (71 citations). Gerard M. Jensen has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include David B. Goodin, Jill Adler‐Moore, Jon Olson, Steven W. Bunte, Duncan E. McRee, Rabi A. Musah, R.J. Rosenfeld, Julie Schwartz, Richard T. Proffitt and Melissa M. Fitzgerald. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Liposome Research, Journal of the American Chemical Society, Journal of Molecular Biology and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.